REQUEST A DEMO
Total
USD $0.00
Search more companies

Cardiodiagnostico Ips Putumayo S.A.S Zomac (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Cardiodiagnostico Ips Putumayo S.A.S Zomac Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Cardiodiagnostico Ips Putumayo S.A.S Zomac is an enterprise in Colombia, with the main office in Mocoa. The company operates in the Ambulatory Health Care Services industry. It was first established on October 09, 2020. There was a net sales revenue increase of 141.11% reported in Cardiodiagnostico Ips Putumayo S.A.S Zomac’s latest financial highlights for 2025. During that time, Cardiodiagnostico Ips Putumayo S.A.S Zomac’s total assets grew by 22.15%. Cardiodiagnostico Ips Putumayo S.A.S Zomac’s net profit margin decreased by 0.94% in 2025.

Headquarters
Cr 7 9 17 Brr Centro
Mocoa; Putumayo;

Contact Details: Purchase the Cardiodiagnostico Ips Putumayo S.A.S Zomac report to view the information.

Basic Information
Registered Capital:
Purchase the Cardiodiagnostico Ips Putumayo S.A.S Zomac report to view the information.
Financial Auditors:
Purchase the Cardiodiagnostico Ips Putumayo S.A.S Zomac report to view the information.
Incorporation Date:
October 09, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Cardiodiagnostico Ips Putumayo S.A.S Zomac report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
141.11%
Total Operating Revenue
141.11%
Operating Profit
197.29%
EBITDA
197.29%
Net Profit/Loss for the Period
124.09%
Total Assets
22.15%
Total Equity
-6.79%
Operating Profit Margin
4.75%
Net Profit Margin
-0.94%
Return on Equity (ROE)
35.5%
Quick Ratio
-1.73%
Cash Ratio
-0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?